What Treatments to Expect for Triple-Negative Breast Cancer

Triple-negative breast cancer, or TNBC, is defined by its lack of estrogen, progesterone, and HER2 receptors, and it demands a distinct treatment approach. The article notes that standard options include chemotherapy, surgery, and radiation, with other remedies providing symptom relief but not tumor reversal or cure. Treatment choice depends on tumor size, grade, and stage, as well as lymph node involvement. The text emphasizes that there are no targeted hormonal or HER2 therapies for TNBC, making systemic treatment and local control central to management. Factors such as tumor biology guide whether treatments occur before or after surgery. Surgical options described include lumpectomy (breast-conserving surgery) and mastectomy, with axillary lymph node dissection sometimes performed. Lumpectomy may be followed by radiation; without radiation, recurrence risk is higher than with more extensive surgery. Mastectomy types range from simple to radical, including nipple-sparing variants, and can reduce recurrence risk in certain patients. The article notes that the choice of procedure depends on cancer spread, breast size, patient preference, and risk of recurrence, as well as genetic factors such as BRCA status in some cases. The overall message is that treatment for TNBC relies on multimodal strategy tailored to individual tumor characteristics.